Skip to main content
Clinical Trials/NCT03039556
NCT03039556
Completed
Not Applicable

The Influence of Acute Physical Inactivity on Metabolic Function in Older Men and Women

McMaster University1 site in 1 country22 target enrollmentSeptember 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Older Adults
Sponsor
McMaster University
Enrollment
22
Locations
1
Primary Endpoint
Change in Insulin Sensitivity
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

This study investigates the effects of two weeks of reduced daily ambulation and a subsequent return to normal physical activity on metabolic health of older adults.

Detailed Description

Aging results in a progressive loss of muscle mass that is accelerated by periods of muscular disuse, common for older adults during hospitalization or convalescence from illness. Transient physical inactivity has been shown to cause muscular atrophy and impairments in insulin sensitivity in both younger and older adults. However, the recovery capacity of older adults after such physical inactivity remains unknown. This study aims to determine the impact of two weeks of daily step reduction to ≤1000 steps per day, an experimental model mimicking short-term physical inactivity, on glycemic control in older adults and further investigate whether older adults are able to recover from the consequences of this inactivity simply by returning to their habitual activity for 14 days.

Registry
clinicaltrials.gov
Start Date
September 2015
End Date
May 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Stuart Phillips

Professor

McMaster University

Eligibility Criteria

Inclusion Criteria

  • Non-smoker

Exclusion Criteria

  • Use of assistive walking devices
  • Chronic use of analgesic or anti-inflammatory drugs
  • History of neuromuscular problems or muscle and/or bone wasting disease
  • Acute or chronic illness including cardiac, pulmonary, liver or kidney abnormalities, uncontrolled hypertension, insulin or non-insulin dependent diabetes or other metabolic disorders
  • Daily use of statins, particularly simvastatin and atorvastatin
  • Use of medications known to affect protein metabolism
  • Normally complete fewer than 3000 steps per day

Outcomes

Primary Outcomes

Change in Insulin Sensitivity

Time Frame: Measured at the end of each behavioural intervention (Week 1, Week 3, Week 5)

Assessed via Matsuda ISI

Secondary Outcomes

  • Change in Muscle Protein Synthesis(Measured at the end of each behavioural intervention (Week 1, Week 3, Week 5))
  • Change in lean tissue mass(Measured at the end of each behavioural intervention (Week 1, Week 3, Week 5))
  • Change in Peak Isometric Maximal Voluntary Leg Extension Strength(Measured at the end of each behavioural intervention (Week 1, Week 3, Week 5))

Study Sites (1)

Loading locations...

Similar Trials